Index
S&P 500
Market Cap
19.46B
Enterprise Value
22.60B
Income
651.90M
Sales
4.40B
Book/sh
19.95
Cash/sh
1.27
Employees
10000
IPO
Jun 13, 2016
P/E
31.18
Forward P/E
19.72
PEG
2.03
P/S
4.43
P/B
3.28
P/C
51.57
P/FCF
17.92
EV/EBITDA
17.21
EV/Sales
5.14
Quick Ratio
0.98
Current Ratio
1.23
Debt/Eq
0.59
LT Debt/Eq
0.59
Option/Short
Yes / Yes
EPS (ttm)
2.10
EPS next Y
3.31
EPS next Q
0.89
EPS this Y
14.02%
EPS next Y
7.27%
EPS next 5Y
9.70%
EPS past 3/5Y
-6.14% -16.65%
Sales past 3/5Y
-10.62% -2.14%
EPS Y/Y TTM
19.92%
Sales Y/Y TTM
-22.06%
EPS Q/Q
244.00%
Sales Q/Q
7.83%
Insider Own
0.39%
Insider Trans
-10.12%
Inst Own
113.82%
Inst Trans
0.37%
ROA
5.62%
ROE
10.56%
ROIC
6.89%
Gross Margin
59.36%
Oper. Margin
19.63%
Profit Margin
14.83%
SMA20
6.00%
SMA50
11.86%
SMA200
10.81%
Trades
Shs Outstand
298.10M
Shs Float
296.48M
52W High
68.94 -5.18%
52W Low
49.99 30.78%
Volatility
3.04% 2.61%
ATR (14)
1.77
RSI (14)
65.14
Beta
1.01
Rel Volume
1.45
Avg Volume
2.45M
Volume
3,568,036
Perf Week
0.21%
Perf Month
15.86%
Perf Quarter
5.86%
Perf Half Y
8.17%
Perf YTD
18.40%
Perf Year
27.98%
Perf 3Y
32.29%
Perf 5Y
10.24%
Perf 10Y
103.04%
Prev Close
65.42
Price
65.37
Change %
-0.08%
Analysts 14 incl. previous ratings
Rating Distribution 2 Buy · 10 Hold · 2 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Sep 28, 2026 Initiated E Evercore ISI
In-line $60 -8.2% May 11, 2026 Upgrade A Argus
Hold → Buy $68 +4.0% Jan 16, 2026 Downgrade J JP Morgan
Neutral → Underweight $57 -12.8% Jan 05, 2026 Downgrade M Mizuho
Outperform → Underperform $51 -22.0% Oct 15, 2025 Downgrade J JP Morgan
Overweight → Neutral $53 -18.9% Sep 02, 2025 Downgrade M Morgan Stanley
Overweight → Equal-Weight $50 -23.5% Aug 14, 2025 Downgrade B Barclays
Overweight → Equal Weight $54 -17.4% Jul 31, 2025 Downgrade T Truist
Buy → Hold $55 -15.9% Jul 22, 2025 Downgrade M Melius
Buy → Hold $62 -5.2% Jul 15, 2025 Downgrade T TD Cowen
Buy → Hold $50 -23.5% Apr 09, 2025 Downgrade E Exane BNP Paribas
Outperform → Neutral $67 +2.5% Dec 09, 2024 Downgrade C Citigroup
Buy → Neutral $92 → $86 +31.6% Nov 18, 2024 Downgrade A Argus
Buy → Hold Nov 13, 2024 Initiated U UBS
Neutral $84 +28.5% Oct 10, 2024 Upgrade J JP Morgan
Neutral → Overweight $90 → $92 +40.7% Sep 06, 2024 Upgrade M Mizuho
Neutral → Outperform $80 → $90 +37.7% Sep 06, 2024 Initiated M Morgan Stanley
Overweight $89 +36.1% Sep 06, 2024 Downgrade W Wolfe Research
Outperform → Peer Perform Sep 05, 2024 Upgrade R Raymond James
Mkt Perform → Outperform Jul 08, 2024 Upgrade T TD Cowen
Hold → Buy $75 → $90 +37.7%
Show Previous Ratings
Nov-04-26 03:00PM
Nov-02-26 08:30AM
Oct-28-26 02:28PM
10:19AM
08:30AM
07:30AM
Loading…
07:30AM
03:30AM
Oct-27-26 11:30AM
09:00AM
Oct-22-26 04:15PM
08:30AM
02:30AM
Oct-20-26 09:00AM
Sep-30-26 04:30PM
Sep-28-26 09:39AM
08:30AM
Loading…
08:30AM
Sep-15-26 03:30AM
Sep-10-26 04:30PM
Sep-03-26 09:55AM
Sep-02-26 08:30AM
Sep-01-26 04:30PM
Aug-20-26 04:15PM
Aug-18-26 08:00AM
Jul-29-26 04:30PM
07:30AM
Jul-21-26 09:31AM
08:00AM
Jul-09-26 03:00AM
Jul-08-26 08:00AM
Jul-07-26 06:36PM
07:30AM
Loading…
Jul-01-26 07:30AM
Jun-29-26 10:56AM
Jun-26-26 07:20AM
Jun-24-26 06:00AM
Jun-22-26 04:21PM
Jun-10-26 04:05PM
Jun-09-26 04:00PM
May-12-26 07:41PM
08:30AM
May-11-26 09:44AM
May-07-26 07:00AM
May-05-26 07:30AM
May-04-26 02:07PM
06:30AM
May-01-26 03:17AM
Apr-30-26 07:30AM
Apr-28-26 07:00AM
Apr-02-26 03:00PM
Mar-23-26 08:00AM
Mar-18-26 10:15AM
Mar-17-26 07:55AM
Mar-16-26 09:00AM
Mar-13-26 09:58AM
Mar-06-26 09:00AM
Mar-05-26 10:33PM
Mar-03-26 04:30PM
Feb-25-26 04:30PM
Feb-23-26 11:02PM
Feb-20-26 07:19AM
Feb-18-26 10:15AM
Feb-11-26 07:06AM
04:24AM
12:40AM
Feb-10-26 10:26AM
Feb-09-26 09:56AM
Feb-06-26 09:13AM
Feb-05-26 12:08PM
09:00AM
02:28AM
01:13AM
12:37AM
Feb-04-26 06:01PM
01:26PM
12:26PM
11:29AM
11:12AM
10:03AM
09:30AM
07:59AM
07:30AM
Feb-02-26 10:09PM
04:30PM
Jan-28-26 08:29AM
Jan-21-26 07:18AM
Jan-20-26 08:00AM
03:00AM
Jan-16-26 09:32AM
Jan-15-26 09:00AM
Jan-13-26 07:29AM
Jan-11-26 11:05PM
Jan-07-26 04:30PM
Jan-05-26 10:00AM
Dec-26-25 09:08AM
Dec-24-25 08:52AM
Dec-12-25 03:46PM
Dec-09-25 03:15AM
Dec-02-25 04:34PM
Nov-27-25 10:38PM
Nov-25-25 08:53AM
Nov-24-25 07:08AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mulhall Christopher M. VP - Chief Accounting Officer Oct 30 '26 Option Exercise 40.26 11,548 464,938 62,560 Nov 02 07:01 PM Mulhall Christopher M. VP - Chief Accounting Officer Oct 30 '26 Option Exercise 40.60 6,883 279,481 23,690 Nov 02 07:01 PM Mulhall Christopher M. VP - Chief Accounting Officer Oct 30 '26 Sale 65.56 17,962 1,177,589 44,598 Nov 02 07:01 PM Mulhall Christopher M. VP - Chief Accounting Officer Oct 30 '26 Sale 65.57 8,093 530,658 15,597 Nov 02 07:01 PM Underwood Peter C SVP - Chief Legal Officer Oct 30 '26 Option Exercise 34.85 48,442 1,688,204 127,560 Nov 02 07:01 PM Underwood Peter C SVP - Chief Legal Officer Oct 30 '26 Sale 64.60 48,442 3,129,353 79,118 Nov 02 07:01 PM Underwood Peter C Officer Oct 30 '26 Proposed Sale 64.60 48,442 3,129,464 Oct 30 03:55 PM Underwood Peter C SVP - Chief Legal Officer Aug 10 '26 Sale 61.59 8,662 533,493 79,118 Aug 11 05:14 PM Underwood Peter C Officer Aug 10 '26 Proposed Sale 61.59 8,662 533,493 Aug 10 05:46 PM Branderiz Eric Former Director Jun 18 '26 Proposed Sale 61.76 15,897 981,825 Jun 18 12:54 PM Underwood Peter C SVP - Chief Legal Officer May 04 '26 Option Exercise 28.92 47,557 1,375,348 135,337 May 06 04:52 PM Underwood Peter C SVP - Chief Legal Officer May 04 '26 Sale 60.81 47,557 2,891,941 87,780 May 06 04:52 PM Underwood Peter C Officer May 04 '26 Proposed Sale 60.81 47,557 2,892,001 May 04 11:56 AM Schwarz Jonathan L Former Officer Mar 23 '26 Proposed Sale 56.23 1,692 95,133 Mar 23 03:18 PM Walker Stacey A. Former Officer Mar 03 '26 Proposed Sale 57.81 7,030 406,411 Mar 03 03:12 PM Schwarz Jonathan L Former Officer Feb 26 '26 Proposed Sale 59.79 1,675 100,154 Feb 26 05:05 PM Walker Stacey A. Former Officer Feb 26 '26 Proposed Sale 59.74 11,391 680,496 Feb 26 03:11 PM MITCHELL KATE Director Feb 18 '26 Option Exercise 29.58 7,131 210,935 38,906 Feb 19 05:12 PM MITCHELL KATE Director Feb 18 '26 Sale 58.34 7,131 416,023 31,775 Feb 19 05:12 PM MITCHELL KATE Director Feb 18 '26 Proposed Sale 58.34 7,131 416,034 Feb 18 04:41 PM Underwood Peter C SVP - Chief Legal Officer Nov 10 '25 Option Exercise 28.92 58,133 1,681,206 138,208 Nov 12 04:46 PM Underwood Peter C SVP - Chief Legal Officer Nov 10 '25 Sale 51.28 58,133 2,981,060 80,075 Nov 12 04:46 PM Underwood Peter C Officer Nov 10 '25 Proposed Sale 51.28 58,133 2,980,795 Nov 10 03:19 PM
Fortive Corp. engages in the design, development, manufacturing, and marketing of professional and engineered products, software, and services for a variety of end markets. It operates through the following segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides solutions to accelerate industrial and facility reliability and performance, as well as compliance and safety across a range of vertical end markets, including manufacturing, process industries, healthcare, utilities and power, communications, and electronics. The Precision Technologies segment supplies technologies such as electrical test and measurement instruments and services, energetic material devices, and a broad portfolio of sensor and control system solutions. The Advanced Healthcare Solutions segment serves healthcare customers with products and services for critical activities, including instrument and device reprocessing, instrument tracking, cell therapy equipment design and manufacturing, biomedical test tools, radiation safety monitoring, and asset management. The company was founded by James A. Lico and Stacey A. Walker on November 10, 2015 and is headquartered in Everett, WA.
President Mr. Olumide O. Soroye J.D.
Senior VP & CFO Mr. Mark D. Okerstrom J.D.
Senior VP & Chief Legal Officer Mr. Peter C. Underwood J.D.
Chief Accounting Officer Mr. Christopher M. Mulhall
Vice President of Investor Relations Ms. Christina Jones